Lataa...
Therapeutic Advances in Oncology
Around 77 new oncology drugs were approved by the FDA in the past five years; however, most cancers remain untreated. Small molecules and antibodies are dominant therapeutic modalities in oncology. Antibody-drug conjugates, bispecific antibodies, peptides, cell, and gene-therapies are emerging to ad...
Tallennettuna:
| Julkaisussa: | Int J Mol Sci |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7922397/ https://ncbi.nlm.nih.gov/pubmed/33670524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22042008 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|